Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: inside layer (24), coating (68), liner (5)

Crizotinib Ver 1

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CRIZOTINIB This protocol may require funding Regimen NSCLC - Crizotinib Indication The treatment of
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CrizotinibVer1.pdf

Abiraterone-Prednisolone ver1.1

Description: Chemotherapy Protocol PROSTATE ABIRATERONE-PREDNISOLONE Funding may be required for specific indications Regimen Prostate-Abiraterone-Prednisolone Indication Second line treatment of
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Abiraterone-Prednisolone-ver1.1.pdf

Atezolizumab(1680-28days)

Description: Chemotherapy Protocol GENITOURINARY CANCER Atezolizumab (1680mg-28 days) Regimen • Urothelial– Atezolizumab (1680mg-28 days) Indication • This protocol was developed in response
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Atezolizumab1680-28days.pdf

Trabectedin v1

Description: Chemotherapy Protocol SARCOMA Regimen TRABECTEDIN Sarcoma-Trabectedin Indication Trabectedin is recommended as a possible treatment for people with advanced soft tissue
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Trabectedin-v1.pdf

MyelomaCTDa28CyclophosphamideDexamethasoneThalidomideAttenuated(CTDa)Ver1

Description: Chemotherapy Protocol MULTIPLE MYELOMA CTDa (28)-CYCLOPHOSPHAMIDE-DEXAMETHASONE-THALIDOMIDE (ATTENUATED) (CTDa-28) There are multiple versions of this protocol in use
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaCTDa28CyclophosphamideDexamethasoneThalidomideAttenuatedCTDaVer1.pdf

ICE website information

Description: Patient requires a radiology procedure All radiology exams can be found on ICE under the “GP Radiology” tab For a chest
Url: /Media/UHS-website-2019/Docs/Services/Radiology/ICE-website-information.pdf

Eye injuries in children - patient information

Description: This factsheet highlights some of the common causes of eye injuries, ways to prevent eye injuries and what you can do
Url: /Media/UHS-website-2019/Patientinformation/Eyes/Eye-injuries-in-children-2362-PIL.PDF

AmsacrineCytarabineEtoposide_MACE

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA AMSACRINE-CYTARABINE-ETOPOSIDE In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Amsacrine-Cytarabine-Etoposide (MACE) Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AmsacrineCytarabineEtoposide-MACE.pdf

Etoposide PO

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER ETOPOSIDE ORAL Regimen Ovary-Etoposide Oral Indication Second line or subsequent treatment of recurrent platinum resistant ovarian
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/EtoposidePO.pdf

Cetuximab (500)-Fluorouracil-Folinic Acid-Oxalplatin

Description: Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB(500)-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)OXALIPLATIN Regimen This regimen may require funding • Colorectal Cancer
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab500-Fluorouracil-FolinicAcid-Oxalplatin.pdf

221 to 230 of 743

Previous … 21 22 23 24 25 … Next